• Comprehensive and up-to-date coverage of the epidemiology, molecular pathogenesis, and cytogenetics of ALL
• Extensive discussion of clinical trial data in childhood and adult ALL
• Chapters devoted to in-depth coverage of key aspects of therapy including use of asparaginase, treatment of central nervous system ALL, and management of long-term sequelae
• Detailed coverage of emerging areas including minimal residual disease monitoring and pharmacogenomics
• Discussion of novel therapies including bispecific T-cell engaging antibody therapy and chimeric antigen receptor expressing T-cell therapy.
... Read more Read less
